Page last updated: 2024-08-23

ng-nitroarginine methyl ester and Leukemia L 1210

ng-nitroarginine methyl ester has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giermasz, A; Gołab, J; Jakóbisiak, M; Jalili, A; Stokłosa, T; Zagozdzon, R1

Other Studies

1 other study(ies) available for ng-nitroarginine methyl ester and Leukemia L 1210

ArticleYear
The potentiated antileukemic effects of doxorubicin and interleukin-12 combination are not dependent on nitric oxide production.
    Cancer letters, 1999, Dec-01, Volume: 147, Issue:1-2

    Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Crosses, Genetic; Doxorubicin; Drug Synergism; Enzyme Inhibitors; Female; Interleukin-12; Leukemia L1210; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Spleen; Survival Rate

1999